However, according to the study, the production of TGF-β1 in patients with CML is higher and IL-10 is lower than in normal subjects, suggesting the possibility of immune bias during the immunological surveillance of CML cells. The gene discussed is TGFB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.